Although direct links between ANGPTL3 and IBD have not been extensively documented, recent studies have shown that the specific antisense oligonucleotide, vupanorsen, which inhibits ANGPTL3 synthesis, significantly increases hepatic steatosis (fatty liver). This evidence concerns the gene ANGPTL3 and inflammatory bowel disease.